Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1116072.RAhA3_C9Ouxp0Pl-LQ1tmseidtVIViYG_32l34apDHPZ0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1116072.RAhA3_C9Ouxp0Pl-LQ1tmseidtVIViYG_32l34apDHPZ0130_assertion type Assertion NP1116072.RAhA3_C9Ouxp0Pl-LQ1tmseidtVIViYG_32l34apDHPZ0130_head.
- NP1116072.RAhA3_C9Ouxp0Pl-LQ1tmseidtVIViYG_32l34apDHPZ0130_assertion description "[Furthermore, to investigate the effect of treatment modalities (transsphenoidal surgery (TS), somatostatin analogs (SAs), and pegvisomant (PGV)) on glucose metabolism and inflammatory biomarkers in acromegaly.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1116072.RAhA3_C9Ouxp0Pl-LQ1tmseidtVIViYG_32l34apDHPZ0130_provenance.
- NP1116072.RAhA3_C9Ouxp0Pl-LQ1tmseidtVIViYG_32l34apDHPZ0130_assertion evidence source_evidence_literature NP1116072.RAhA3_C9Ouxp0Pl-LQ1tmseidtVIViYG_32l34apDHPZ0130_provenance.
- NP1116072.RAhA3_C9Ouxp0Pl-LQ1tmseidtVIViYG_32l34apDHPZ0130_assertion SIO_000772 24092547 NP1116072.RAhA3_C9Ouxp0Pl-LQ1tmseidtVIViYG_32l34apDHPZ0130_provenance.
- NP1116072.RAhA3_C9Ouxp0Pl-LQ1tmseidtVIViYG_32l34apDHPZ0130_assertion wasDerivedFrom befree-2016 NP1116072.RAhA3_C9Ouxp0Pl-LQ1tmseidtVIViYG_32l34apDHPZ0130_provenance.
- NP1116072.RAhA3_C9Ouxp0Pl-LQ1tmseidtVIViYG_32l34apDHPZ0130_assertion wasGeneratedBy ECO_0000203 NP1116072.RAhA3_C9Ouxp0Pl-LQ1tmseidtVIViYG_32l34apDHPZ0130_provenance.